Last 12 months
Inside the activity.
0 purchase rows · 34 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 9 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2020 Filed Apr 3, 2020 20:02 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionCommon Stock | 58,519 | $3.02 | $176,727.38 |
DisclosureSEC source: 0001593968-20-000976 · primary_01.xml · nonDerivative · entry 2 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,227 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 20:02 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionCommon Stock | 10,000 | $1.95 | $19,500.00 |
DisclosureSEC source: 0001593968-20-000976 · primary_01.xml · nonDerivative · entry 1 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,708 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| March 31, 2020 Filed Jan 28, 2021 21:19 UTC |
Flynn Sean C.VP, General Counsel
|
GrantCommon Stock | 809 | $7.79 | $6,305.75 |
DisclosureSEC source: 0001593968-21-000237 · primary_01.xml · nonDerivative · entry 1 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 809 F1 · shares: Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 21:26 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 13,125 | $0.00 Strike: $2.75 | $0.00 |
DisclosureSEC source: 0001593968-20-000454 · primary_01.xml · derivative · entry 4 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,750 Underlying: Common Stock · 13,125 shares Expires 2027-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options, representing the right to purchase a total of 210,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 8, 2017, which was one quarter after the date on which the option was granted. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 21:26 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,313 | $0.00 Strike: $1.95 | $0.00 |
DisclosureSEC source: 0001593968-20-000454 · primary_01.xml · derivative · entry 3 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,183 Underlying: Common Stock · 10,313 shares Expires 2026-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options, representing the right to purchase a total of 165,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 9, 2016, which was one quarter after the date on which the option was granted. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 21:26 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionCommon Stock | 13,125 | $2.75 | $36,093.75 |
DisclosureSEC source: 0001593968-20-000454 · primary_01.xml · nonDerivative · entry 2 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,229 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 21:26 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionCommon Stock | 10,313 | $1.95 | $20,110.35 |
DisclosureSEC source: 0001593968-20-000454 · primary_01.xml · nonDerivative · entry 1 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,104 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:08 UTC |
Colangelo DominickDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 5,555 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001593968-20-000437 · primary_01.xml · derivative · entry 3 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,555 Underlying: Common Stock · 5,555 shares Expires 2030-02-11 F1 · derivative.exercise_date: These options shall begin vesting on February 11, 2020 and shall vest and become exercisable in equal quarterly installments over the course of the following four (4) year period. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:08 UTC |
Colangelo DominickDirector · President and CEO
|
GrantRestricted Stock Unit · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-20-000437 · primary_01.xml · derivative · entry 2 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F3 · derivative.exercise_date: These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 11, 2021. The remaining RSUs will vest in annual installments on February 11, 2022, February 11, 2023, and February 11, 2024, respectively. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:08 UTC |
Colangelo DominickDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 219,445 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001593968-20-000437 · primary_01.xml · derivative · entry 1 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,445 Underlying: Common Stock · 219,445 shares Expires 2030-02-11 F1 · derivative.exercise_date: These options shall begin vesting on February 11, 2020 and shall vest and become exercisable in equal quarterly installments over the course of the following four (4) year period. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:05 UTC |
Hopper Jonathan MarkChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 41,652 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001593968-20-000436 · primary_01.xml · derivative · entry 3 Hopper Jonathan Mark · CIK 0001626325 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,652 Underlying: Common Stock · 41,652 shares Expires 2030-02-11 F4 · derivative.exercise_date: These options shall begin vesting on February 11, 2020 and shall vest and become exercisable in equal quarterly installments over the course of the following four (4) year period. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:05 UTC |
Hopper Jonathan MarkChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 7,098 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001593968-20-000436 · primary_01.xml · derivative · entry 2 Hopper Jonathan Mark · CIK 0001626325 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,098 Underlying: Common Stock · 7,098 shares Expires 2030-02-11 F4 · derivative.exercise_date: These options shall begin vesting on February 11, 2020 and shall vest and become exercisable in equal quarterly installments over the course of the following four (4) year period. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:05 UTC |
Hopper Jonathan MarkChief Medical Officer
|
GrantRestricted Stock Unit · Derivative | 6,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-20-000436 · primary_01.xml · derivative · entry 1 Hopper Jonathan Mark · CIK 0001626325 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,500 Underlying: Common Stock · 6,500 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F2 · derivative.exercise_date: These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 11, 2021. The remaining RSUs will vest in annual installments on February 11, 2022, February 11, 2023, and February 11, 2024, respectively. F3 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:04 UTC |
Halpin MichaelChief Operating Officer
|
GrantStock Option (right to buy) · Derivative | 6,699 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001593968-20-000435 · primary_01.xml · derivative · entry 3 Halpin Michael · CIK 0001778858 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,699 Underlying: Common Stock · 6,699 shares Expires 2030-02-11 F1 · derivative.exercise_date: These options shall begin vesting on February 11, 2020 and shall vest and become exercisable in equal quarterly installments over the course of the following four (4) year period. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:04 UTC |
Halpin MichaelChief Operating Officer
|
GrantRestricted Stock Unit · Derivative | 14,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-20-000435 · primary_01.xml · derivative · entry 2 Halpin Michael · CIK 0001778858 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F3 · derivative.exercise_date: These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 11, 2021. The remaining RSUs will vest in annual installments on February 11, 2022, February 11, 2023, and February 11, 2024, respectively. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:04 UTC |
Halpin MichaelChief Operating Officer
|
GrantStock Option (right to buy) · Derivative | 98,301 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001593968-20-000435 · primary_01.xml · derivative · entry 1 Halpin Michael · CIK 0001778858 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,301 Underlying: Common Stock · 98,301 shares Expires 2030-02-11 F1 · derivative.exercise_date: These options shall begin vesting on February 11, 2020 and shall vest and become exercisable in equal quarterly installments over the course of the following four (4) year period. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:03 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
GrantRestricted Stock Unit · Derivative | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-20-000434 · primary_01.xml · derivative · entry 3 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F3 · derivative.exercise_date: These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 11, 2021. The remaining RSUs will vest in annual installments on February 11, 2022, February 11, 2023, and February 11, 2024, respectively. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:03 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
GrantStock Option (right to buy) · Derivative | 5,555 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001593968-20-000434 · primary_01.xml · derivative · entry 2 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,555 Underlying: Common Stock · 5,555 shares Expires 2030-02-11 F1 · derivative.exercise_date: These options shall begin vesting on February 11, 2020 and shall vest and become exercisable in equal quarterly installments over the course of the following four (4) year period. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:03 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
GrantStock Option (right to buy) · Derivative | 84,445 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001593968-20-000434 · primary_01.xml · derivative · entry 1 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,445 Underlying: Common Stock · 84,445 shares Expires 2030-02-11 F1 · derivative.exercise_date: These options shall begin vesting on February 11, 2020 and shall vest and become exercisable in equal quarterly installments over the course of the following four (4) year period. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 22:03 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,937 | $17.28 | $119,871.36 |
DisclosureSEC source: 0001593968-20-000376 · primary_01.xml · derivative · entry 3 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,813 Underlying: Common Stock · 6,937 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F4 · derivative.exercise_date: The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 6, 2019. The remaining RSUs will vest in annual installments on February 6, 2021, February 6, 2022, and February 6, 2023, respectively. F5 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 22:03 UTC |
Colangelo DominickDirector · President and CEO
|
Tax withholdingCommon Stock | 3,179 | $17.28 | $54,933.12 |
DisclosureSEC source: 0001593968-20-000376 · primary_01.xml · nonDerivative · entry 2 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,791 F2 · shares: These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of Restricted Stock Units. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 22:03 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionCommon Stock | 6,937 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-20-000376 · primary_01.xml · nonDerivative · entry 1 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,970 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of common stock were acquired by the Reporting person as a result of the vesting of RSUs granted to the Reporting Person on February 6, 2019. The remaining RSUs will vest in annual installments on February 6, 2021, February 6, 2022, and February 6, 2023, respectively. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 22:04 UTC |
Halpin MichaelChief Operating Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,875 | $17.28 | $32,400.00 |
DisclosureSEC source: 0001593968-20-000377 · primary_01.xml · derivative · entry 3 Halpin Michael · CIK 0001778858 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,625 Underlying: Common Stock · 1,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F5 · derivative.exercise_date: The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 6, 2019. The remaining RSUs will vest in annual installments on February 6, 2021, February 6, 2022, and February 6, 2023, respectively. F6 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 22:04 UTC |
Halpin MichaelChief Operating Officer
|
Tax withholdingCommon Stock | 763 | $17.28 | $13,184.64 |
DisclosureSEC source: 0001593968-20-000377 · primary_01.xml · nonDerivative · entry 2 Halpin Michael · CIK 0001778858 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,401 F3 · shares: These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of Restricted Stock Units. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 22:04 UTC |
Halpin MichaelChief Operating Officer
|
Exercise / conversionCommon Stock | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-20-000377 · primary_01.xml · nonDerivative · entry 1 Halpin Michael · CIK 0001778858 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,164 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of common stock were acquired by the Reporting person as a result of the vesting of RSUs granted to the Reporting Person on February 6, 2019. The remaining RSUs will vest in annual installments on February 6, 2021, February 6, 2022, and February 6, 2023, respectively. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 22:02 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,000 | $17.28 | $51,840.00 |
DisclosureSEC source: 0001593968-20-000375 · primary_01.xml · derivative · entry 3 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 3,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F4 · derivative.exercise_date: The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 6, 2019. The remaining RSUs will vest in annual installments on February 6, 2021, February 6, 2022, and February 6, 2023, respectively. F5 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 22:02 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Tax withholdingCommon Stock | 1,460 | $17.28 | $25,228.80 |
DisclosureSEC source: 0001593968-20-000375 · primary_01.xml · nonDerivative · entry 2 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,272 F2 · shares: These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of Restricted Stock Units. Read SEC document |
| February 06, 2020 Filed Feb 10, 2020 22:02 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-20-000375 · primary_01.xml · nonDerivative · entry 1 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,732 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of common stock were acquired by the Reporting person as a result of the vesting of RSUs granted to the Reporting Person on February 6, 2019. The remaining RSUs will vest in annual installments on February 6, 2021, February 6, 2022, and February 6, 2023, respectively. Read SEC document |
| November 11, 2019 Filed Nov 12, 2019 21:03 UTC |
Halpin MichaelChief Operating Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 15,047 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0001593968-19-002108 · primary_01.xml · derivative · entry 3 Halpin Michael · CIK 0001778858 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,953 Underlying: Common Stock · 15,047 shares Expires 2027-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 135,000 shares, became exercisable on April 10, 2018, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company. Read SEC document |
| November 11, 2019 Filed Nov 12, 2019 21:03 UTC |
Halpin MichaelChief Operating Officer
|
SaleCommon Stock | 15,047 | $18.53 | $278,820.91 |
DisclosureSEC source: 0001593968-19-002108 · primary_01.xml · nonDerivative · entry 2 Halpin Michael · CIK 0001778858 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,034 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2019. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). F1 · ownership.direct: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| November 11, 2019 Filed Nov 12, 2019 21:03 UTC |
Halpin MichaelChief Operating Officer
|
Exercise / conversionCommon Stock | 15,047 | $2.65 | $39,874.55 |
DisclosureSEC source: 0001593968-19-002108 · primary_01.xml · nonDerivative · entry 1 Halpin Michael · CIK 0001778858 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,081 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). F1 · ownership.direct: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| October 02, 2019 Filed Oct 3, 2019 20:12 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 16,250 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0001593968-19-001973 · primary_01.xml · derivative · entry 4 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,750 Underlying: Common Stock · 16,250 shares Expires 2027-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 6.25% of these options, representing the right to purchase a total of 90,000 shares, became exercisable immediately on May 22, 2017. An additional 6.25% became exercisable on August 8, 2017 and continue to vest in equal quarterly installments from August 8, 2017, contingent upon the continued service to the Company. Read SEC document |
| October 02, 2019 Filed Oct 3, 2019 20:12 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionCommon Stock | 16,250 | $2.65 | $43,062.50 |
DisclosureSEC source: 0001593968-19-001973 · primary_01.xml · nonDerivative · entry 2 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,033 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 02, 2019 Filed Oct 3, 2019 20:01 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionStock Option (right to buy) · Derivative | 9,827 | $0.00 Strike: $2.75 | $0.00 |
DisclosureSEC source: 0001593968-19-001971 · primary_01.xml · derivative · entry 6 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,548 Underlying: Common Stock · 9,827 shares Expires 2027-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options, representing the right to purchase a total of 70,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 8, 2017, which was one quarter after the date on which the option was granted. Read SEC document |
| October 02, 2019 Filed Oct 3, 2019 20:01 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionStock Option (right to buy) · Derivative | 11,250 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001593968-19-001971 · primary_01.xml · derivative · entry 5 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,519 Underlying: Common Stock · 11,250 shares Expires 2025-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase a total of 180,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted. Read SEC document |
| October 02, 2019 Filed Oct 3, 2019 20:01 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $1.95 | $0.00 |
DisclosureSEC source: 0001593968-19-001971 · primary_01.xml · derivative · entry 4 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 15,000 shares Expires 2026-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options, representing the right to purchase a total of 80,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 9, 2016, which was one quarter after the date on which the option was granted. Read SEC document |
| October 02, 2019 Filed Oct 3, 2019 20:01 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionCommon Stock | 11,250 | $3.02 | $33,975.00 |
DisclosureSEC source: 0001593968-19-001971 · primary_01.xml · nonDerivative · entry 3 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,732 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). F1 · ownership.direct: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| October 02, 2019 Filed Oct 3, 2019 20:01 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionCommon Stock | 9,827 | $2.75 | $27,024.25 |
DisclosureSEC source: 0001593968-19-001971 · primary_01.xml · nonDerivative · entry 2 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,482 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). F1 · ownership.direct: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| October 02, 2019 Filed Oct 3, 2019 20:01 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionCommon Stock | 15,000 | $1.95 | $29,250.00 |
DisclosureSEC source: 0001593968-19-001971 · primary_01.xml · nonDerivative · entry 1 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,655 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). F1 · ownership.direct: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 20:12 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0001593968-19-001973 · primary_01.xml · derivative · entry 3 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 40,000 shares Expires 2027-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 6.25% of these options, representing the right to purchase a total of 90,000 shares, became exercisable immediately on May 22, 2017. An additional 6.25% became exercisable on August 8, 2017 and continue to vest in equal quarterly installments from August 8, 2017, contingent upon the continued service to the Company. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 20:12 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionCommon Stock | 40,000 | $2.65 | $106,000.00 |
DisclosureSEC source: 0001593968-19-001973 · primary_01.xml · nonDerivative · entry 1 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,783 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 20:03 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 58,125 | $0.00 Strike: $2.75 | $0.00 |
DisclosureSEC source: 0001593968-19-001972 · primary_01.xml · derivative · entry 3 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,875 Underlying: Common Stock · 58,125 shares Expires 2027-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase a total of 210,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 8, 2017, which was one quarter after the date on which the option was granted. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 20:03 UTC |
Colangelo DominickDirector · President and CEO
|
SaleCommon Stock | 58,125 | $14.88 | $864,650.06 |
DisclosureSEC source: 0001593968-19-001972 · primary_01.xml · nonDerivative · entry 2 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,783 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 6, 2019. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). F1 · ownership.direct: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 20:03 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionCommon Stock | 58,125 | $2.75 | $159,843.75 |
DisclosureSEC source: 0001593968-19-001972 · primary_01.xml · nonDerivative · entry 1 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,908 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). F1 · ownership.direct: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| August 14, 2019 Filed Aug 16, 2019 20:06 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionStock Option (right to buy) · Derivative | 17,000 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001593968-19-001743 · primary_01.xml · derivative · entry 3 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,769 Underlying: Common Stock · 17,000 shares Expires 2025-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options, representing the right to purchase a total of 180,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted. Read SEC document |
| August 14, 2019 Filed Aug 16, 2019 20:06 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
SaleCommon Stock | 17,000 | $16.62 | $282,546.80 |
DisclosureSEC source: 0001593968-19-001743 · primary_01.xml · nonDerivative · entry 2 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,182 F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2018. Read SEC document |
| August 14, 2019 Filed Aug 16, 2019 20:06 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionCommon Stock | 17,000 | $3.02 | $51,340.00 |
DisclosureSEC source: 0001593968-19-001743 · primary_01.xml · nonDerivative · entry 1 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,182 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2019 Filed Jul 17, 2019 20:17 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionStock Option (right to buy) · Derivative | 17,000 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001593968-19-001638 · primary_01.xml · derivative · entry 3 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,769 Underlying: Common Stock · 17,000 shares Expires 2025-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase a total of 180,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted. Read SEC document |
| July 15, 2019 Filed Jul 17, 2019 20:17 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
SaleCommon Stock | 17,000 | $19.68 | $334,578.70 |
DisclosureSEC source: 0001593968-19-001638 · primary_01.xml · nonDerivative · entry 2 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,182 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2018. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). F1 · ownership.direct: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| July 15, 2019 Filed Jul 17, 2019 20:17 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionCommon Stock | 17,000 | $3.02 | $51,340.00 |
DisclosureSEC source: 0001593968-19-001638 · primary_01.xml · nonDerivative · entry 1 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,182 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). F1 · ownership.direct: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.